New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
05:45 EDTMYGN, AETAetna BRCA testing policy bulletin not a change, says William Blair
William Blair says shares of Myriad Genetics (MYGN) dropped 2% Friday after Aetna (AET) issued a clinical policy bulletin update for BRCA testing that changed the word "Myriad" to "Laboratory." The firm believes the bulletin does not represent a change to the status quo since a number of labs now offer BRCA testing. William Blair keeps an Outperform rating on Myriad.
News For MYGN;AET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 25, 2015
17:03 EDTAETVeracyte signs national network agreement with Aetna
Subscribe for More Information
16:23 EDTAETOn The Fly: Top stock stories for Thursday
Subscribe for More Information
14:44 EDTAETHumana options active on nearing deal to be acquired by Aetna
Subscribe for More Information
13:57 EDTAETHumana spikes on nearing deal to be acquired by Aetna
Subscribe for More Information
13:53 EDTAETHumana nearing deal to be acquired by Aetna, Bloomberg reports
Aetna (AET) is nearing an acquisition of Humana (HUM) and a deal could be reached as early as this weekend, Bloomberg reports, citing people with knowledge of the matter. Aetna's bid includes cash and stock, and talks between the two the companies picked up after Anthem (ANTM) came public with a bid for Cigna (CI), Bloomberg adds. Both Aetna and Cigna bid for Humana, a source told Bloomberg, with Humana's board preferring the offer from Aetna. Shares of Humana are up $14.72 to $198.95 following Bloomberg's report. Reference Link
13:43 EDTAETHumana received offer from Cigna, Aetna, prefers Aetna, Bloomberg says
Subscribe for More Information
13:43 EDTAETAetna nearing deal to acquire Humana, Bloomberg reports
11:06 EDTAETHospitals, insurers climb after Supreme Court rules on ACA subsidies
Subscribe for More Information
10:11 EDTAETACA tax subsidies upheld by Supreme Court
The decision of the Fourth Circuit was affirmed in King v. Burwell by a vote of 6 to 3, according to multiple media reports. The Supreme Court upholding the lower court ruling means that individuals who get health insurance through an exchange established by the federal government will be eligible for tax subsidies in all 50 states. Publicly traded companies in the health insurance space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG). Publicly traded companies in the hospital space include Community Health (CYH), HCA Holdings (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS).
09:40 EDTAETMultiple parties expressing interest in Humana, CNBC reports
Humana (HUM) has received expressions of interest from multiple companies, CNBC's David Faber reports. The interest does not mean multiples bids are forthcoming, Faber added.
June 24, 2015
17:57 EDTAETWall Street applauds Senate giving go-ahead for 'fast track' trade powers
Subscribe for More Information
10:00 EDTAETOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:36 EDTAETAetna initiated with a Sector Perform at RBC Capital
Subscribe for More Information
June 23, 2015
07:44 EDTAETHumana takeover looks unlikely below $210/share, says Leerink
Subscribe for More Information
June 22, 2015
18:56 EDTAETCigna/Anthem deal could leave Humana with Aetna as only suitor, Bloomberg says
Subscribe for More Information
08:16 EDTAETAnthem, Cigna deal would be negative for Catamaran, says Leerink
Subscribe for More Information
07:54 EDTAETAnthem, Cigna deal likely to be consummated, says Leerink
Subscribe for More Information
07:16 EDTAETAnthem should be bought after Cigna offer, says Stifel
After Anthem, (ANTM) offered to buy Cigna (CI) and the latter company rejected the bid, Stifel estimates that the deal would have been 10% accretive for Anthem in the first year and 20% accretive in the second year. The firm thinks that accretion from the deal will probably be higher than expected. It also recommends buying Aetna (AET) as it believes that the Anthem offer suggests that Aetna will benefit more than expected from its own deal. The firm is cautious on Humana (HUM), saying that it may lose two potential buyers in Anthem and Cigna, while Humana may retreat if Aetna does not acquire the company quickly.
06:51 EDTAETHealth insurer tie-ups could cut competition, WSJ reports
Subscribe for More Information
06:37 EDTAETHealth insurers may change policies based on King v. Burwell ruling, NYT says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use